Roger P.M. Sutmuller

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

Roger P.M. Sutmuller, Leonie M. van Duivenvoorde, Andrea van Elsas et al. · The Journal of Experimental Medicine · 2001 · 1K citations · Full text

Life Sciences, Immunology, Oncology +17

Toll-like receptor 2 controls expansion and function of regulatory T cells

Roger P.M. Sutmuller · Journal of Clinical Investigation · 2006 · 749 citations · Full text

Life Sciences, Immunology, Host-pathogen Interactions +16

Toll-Like Receptor 2 Suppresses Immunity against <i>Candida albicans</i> through Induction of IL-10 and Regulatory T Cells

Mihai G. Netea, Roger P.M. Sutmuller, Corinna Hermann et al. · The Journal of Immunology · 2004 · 602 citations · Full text

Life Sciences, Immunology, Microbiology +17

<b> <i>In Situ</i> </b> Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity

Martijn H. den Brok, Roger P.M. Sutmuller, Robbert van der Voort et al. · Cancer Research · 2004 · 421 citations · Full text

Life Sciences, Immunology, Oncology +16

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine

Andrea van Elsas, Roger P.M. Sutmuller, Arthur A. Hurwitz et al. · The Journal of Experimental Medicine · 2001 · 307 citations · Full text

Medicine, Immunology, Oncology +17